FLORHAM PARK, NJ - Troy Corp. has been notified of the Annex 1 listing of IPBC, as published on July 29, 2008 in the Official Journal of the European Union. As part of its continued investment, Troy Corp. led the effort of a group of companies to supply a complete dossier to the European Union (EU) authorities to fulfill the requirements of the Biocidal Products Directive (BPD). This dossier contained more than 20 binders full of toxicology, environmental, risk assessment, efficacy data and technical and safety information for one of the world’s key biocidal actives.
“Registration of our active substances (Polyphase®) under the BPD is a key part of our commitment to our customers in the biocides industry,” said Dr. Donald Shaw, Vice President, Development, Troy Corp. “Annex I listing under the BPD represents one of the most significant regulatory approvals in the world. Troy Corp., as a leader in the biocides industry, remains committed to investing the financial and people resources necessary to support approval of active substances in its products worldwide."
Polyphase® (IPBC) was discovered by Troy Corp. in the 1970’s. Troy Corp. has pioneered the development of this active ingredient and related formulated products, creating the world’s leading biocide.
“Annex I listing, together with EPA’s earlier decision to re-register IPBC, ensures that this important material will be available for years to come,” according to Don Shaw.
Polyphase® is one of an extensive product line of highly active, broad-spectrum antimicrobials offered by Troy. Increasingly, Troy’s biocides are being incorporated as antimicrobials into interior and exterior coatings, wood preservatives, caulk and sealants, metalworking fluids and many allied markets. Troy Antimicrobials are fundamental ingredients against the Sick Building Syndrome, a growing concern to the markets Troy serves.